
Marc Steven Greenblatt MD
Associate Professor, Medicine, University of Vermont College of Medicine
Join to View Full Profile
111 Colchester AveBurlington, VT 05401
Phone+1 802-847-8400
Are you Dr. Greenblatt?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Marc Greenblatt, MD is an oncologist in Burlington, Vermont. He is currently licensed to practice medicine in Vermont, New York, and New Mexico. He is an Associate Professor at University of Vermont College of Medicine.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1992 - 1993
- University of New Mexico School of MedicineFellowship, Hematology and Medical Oncology, 1988 - 1991
- University of New Mexico School of MedicineResidency, Internal Medicine, 1983 - 1987
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1983
Certifications & Licensure
- NY State Medical License 2019 - 2026
- VT State Medical License 1995 - 2026
- NM State Medical License 1984 - 2000
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Large-scale application of ClinGen-InSiGHT APC-specific ACMG/AMP variant classification criteria leads to substantial reduction in VUS.Xiaoyu Yin, Marcy Richardson, Andreas Laner, Xuemei Shi, Elisabet Ognedal
American Journal of Human Genetics. 2024-11-07 - 4 citationsAssessment of the evidence yield for the calibrated PP3/BP4 computational recommendations.Sarah L Stenton, Vikas Pejaver, Timothy Bergquist, Leslie G Biesecker, Alicia B Byrne
Genetics in Medicine. 2024-11-01 - 2 citationsCalibration of additional computational tools expands ClinGen recommendation options for variant classification with PP3/BP4 criteria.Timothy Bergquist, Sarah L Stenton, Emily A W Nadeau, Alicia B Byrne, Marc S Greenblatt
Biorxiv. 2024-09-21
Press Mentions
- Risk-Reducing Hysterectomy and Bilateral Salpingo-Oophorectomy in Female Heterozygotes of Pathogenic Mismatch Repair Variants: A Prospective Lynch Syndrome Database ReportDecember 1st, 2020
- Study Provides Clearer Picture of Cancer RiskJanuary 27th, 2014
Grant Support
- InSiGHT-ClinGen Polyposis/Colon Cancer Variant Curation Expert PanelUNIVERSITY OF VERMONT & ST AGRIC COLLEGE2021–2025